| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | -7.73% | +1.53% | -9.26% | -9.26% | — |
| 14d | 1 | +0.00% | -24.69% | -1.07% | -23.62% | -23.62% | — |
| 30d | 1 | +0.00% | -24.69% | -7.04% | -17.65% | -17.65% | — |
| 60d | 1 | +0.00% | -18.45% | +5.08% | -23.54% | -23.54% | — |
| 90d | 1 | +100.00% | +36.66% | +6.58% | +30.07% | +30.07% | — |
| 180d | 1 | +100.00% | +50.37% | +16.26% | +34.11% | +34.11% | — |
| 1y | 1 | +0.00% | -78.00% | +18.63% | -96.64% | -96.64% | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ATYR ATYR PHARMA INC | PURCHASEGRANT Stock grant | 50,000 | — | — | 50,000 | May 11, 2026 | May 13, 2026 ↗ | View → |
| ATYR ATYR PHARMA INC | PURCHASEGRANT Stock grant | 50,000 | — | — | 50,000 | May 1, 2025 | May 2, 2025 ↗ | View → |
| ATYR ATYR PHARMA INC | PURCHASE | 3,750 | $4.00 | $15.0K | 9,750 | Mar 17, 2025 | Mar 17, 2025 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | PURCHASEGRANT Stock grant | 24,000 | — | — | 24,000 | May 22, 2024 | May 23, 2024 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | PURCHASEGRANT Stock grant | 12,000 | — | — | 12,000 | May 17, 2023 | May 19, 2023 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | PURCHASE | 6,000 | — | — | 6,000 | Apr 26, 2023 | Apr 28, 2023 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | SALE | 6,000 | — | — | 0 | Apr 26, 2023 | Apr 28, 2023 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | PURCHASEGRANT Stock grant | 6,000 | — | — | 6,000 | Apr 26, 2022 | Apr 28, 2022 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | PURCHASEGRANT Stock grant | 1,428 | — | — | 1,428 | Apr 28, 2021 | Apr 29, 2021 ↗ | View → |
| APVO APTEVO THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 16,500 | — | — | 16,500 | Jan 29, 2021 | Feb 17, 2021 ↗ | View → |
| APVO APTEVO THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 5,500 | — | — | 5,500 | Jan 29, 2021 | Feb 17, 2021 ↗ | View → |
| APVO APTEVO THERAPEUTICS INC. | SALE SVP & Chief Scientific Officer | 4,814 | — | — | 0 | Jul 27, 2020 | Jul 29, 2020 ↗ | View → |
| APVO APTEVO THERAPEUTICS INC. | SALE SVP & Chief Scientific Officer | 2,407 | — | — | 0 | Jul 27, 2020 | Jul 29, 2020 ↗ | View → |
| APVO APTEVO THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 2,140 | — | — | 2,140 | Jul 27, 2020 | Jul 29, 2020 ↗ | View → |
| APVO APTEVO THERAPEUTICS INC. | SALE SVP & Chief Scientific Officer | 2,072 | — | — | 0 | Jul 27, 2020 | Jul 29, 2020 ↗ | View → |
| APVO APTEVO THERAPEUTICS INC. | SALE SVP & Chief Scientific Officer | 3,908 | — | — | 0 | Jul 27, 2020 | Jul 29, 2020 ↗ | View → |
| APVO APTEVO THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 7,784 | — | — | 7,784 | Jul 27, 2020 | Jul 29, 2020 ↗ | View → |
| APVO APTEVO THERAPEUTICS INC. | SALE SVP & Chief Scientific Officer | 2,779 | — | — | 0 | Jul 27, 2020 | Jul 29, 2020 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | PURCHASEGRANT Stock grant | 1,428 | — | — | 1,428 | May 6, 2020 | May 8, 2020 ↗ | View → |
| APVO APTEVO THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 134,800 | — | — | 134,800 | Feb 18, 2020 | Mar 19, 2020 ↗ | View → |